Sep / 2025

OncoDaily IO OncoDaily GI Hemostasis Today

10/05/2024

May 10, 2024 11:54 pm

May 10, 2024 7:05 pm

May 10, 2024 5:49 pm

May 10, 2024 5:31 pm

May 10, 2024 5:21 pm

May 10, 2024 4:58 pm

May 10, 2024 4:40 pm

May 10, 2024 3:58 pm

May 10, 2024 3:41 pm

May 10, 2024 3:21 pm

…

M	T	W	T	F	S	S
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

10/05/2024

The Canadian Cancer Society is updating its position on breast screening

Oncothon: Pediatric Cancer Drug Development

Piotr Wysocki: Relatlimab does not improve the activity of nivolumab plus chemotherapy

The Sylvester Brain Tumor Institute launched by Sylvester Comprehensive Cancer Center to Personalize Brain Cancer Treatment

Dr. Jill O’Donnell-Tormey was honored as a member of the 2024 Class of Staten Island Advance Women of Achievement – Cancer Research Institute

The first tumor-agnostic study of a HER2-directed antibody-drug conjugate – MSKCC

Myeloma Paper of the Day, May 10th, suggested by Robert Orlowski

Sunil Verma: Great to be at the Milken Institute Global Conference in Los Angeles!

Noubar Afeyan: Our partnership with Novo Nordisk brings together the best of two companies in drug development

Karen Knudsen: Thank you to QVC for including me in the Q50 Collective

Headlines

10/05/2024

The Canadian Cancer Society is updating its position on breast screening

Oncothon: Pediatric Cancer Drug Development

Piotr Wysocki: Relatlimab does not improve the activity of nivolumab plus chemotherapy

The Sylvester Brain Tumor Institute launched by Sylvester Comprehensive Cancer Center to Personalize Brain Cancer Treatment

Dr. Jill O’Donnell-Tormey was honored as a member of the 2024 Class of Staten Island Advance Women of Achievement – Cancer Research Institute

The first tumor-agnostic study of a HER2-directed antibody-drug conjugate – MSKCC

Myeloma Paper of the Day, May 10th, suggested by Robert Orlowski

Sunil Verma: Great to be at the Milken Institute Global Conference in Los Angeles!

Noubar Afeyan: Our partnership with Novo Nordisk brings together the best of two companies in drug development

Karen Knudsen: Thank you to QVC for including me in the Q50 Collective

Headlines

OncoDaily

Oncology

cancer

fight against cancer

Global fight against cancer

cancer care

Breast Cancer

ASCO

Lung cancer

Cancer research

MD Anderson Cancer Center

cancer awareness

NSCLC

ESMO

immunotherapy

cancer treatment

Research

ASCO24

Headlines

colorectal cancer

Childhood Cancer

prostate cancer

AACR

clinical trials

FDA

Dana-Farber Cancer Institute

UICC

American Cancer Society

European Cancer Organisation

NCI

National Cancer Institute

healthcare

SIOP

ASCO25

chemotherapy

Vivek Subbiah

AI

American Society of Clinical Oncology

Paolo Tarantino

IASLC

WHO

Robert Orlowski

multiple myeloma

Memorial Sloan Kettering Cancer Center

Zainab Shinkafi-Bagudu

radiation oncology

Myeloma Paper of the Day

cervical cancer

Myeloma

patient care

European School of Oncology

Sitemap